KANGSTEM BIOTECH CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 217730 for the last quarter is 783.33 M KRW, and it's 65.58% lower compared to the previous quarter. The net income of Q3 24 is -4.03 B KRW.